Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-13

FDA Approved: XENAZINE — Supplemental Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Xenazine (tetrabenazine) submitted by Lundbeck Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xenazine (tetrabenazine)

Snippet

SUPPL AP for XENAZINE (TETRABENAZINE)